A cardiovascular disease risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients most benefit from statin therapy, according to a recent study published in JAMA Cardiology.
Scientists have discovered more than 100 new epigenetic biomarkers that may help predict cardiovascular disease risk and inform preventive care measures to improve long-term outcomes, according to a recent study published in Circulation.
An international multi-center study revealed how diet plays a greater role in the prevalence of obesity globally than was previously understood, according to findings published in the Proceedings of the National Academy of Sciences.
A new risk prediction tool developed by the American Heart Association (AHA) estimated cardiovascular disease (CVD) risk in a diverse patient cohort more accurately than current models, according to a recent study published in Nature Medicine.
Poor prepregnancy cardiovascular health is associated with a higher risk of developing gestational diabetes and coronary artery calcium in midlife, according to a recent Northwestern Medicine study.
Northwestern Medicine investigators have created a novel blood test that identifies adults who may be at increased risk of developing severe respiratory illnesses, according to a recent study published in the American Journal of Respiratory and Critical Care Medicine.
Since 2013, Feinberg medical students have provided cardiovascular disease risk assessments and health counseling to underserved community members across Chicago through the Keep Your Heart Healthy program.
Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according to a recent Northwestern Medicine study.
Dietary acculturation may increase the risk of heart disease for people of Hispanic or Latino heritage in the U.S., according to a study published in Circulation.
Proteomic analysis of blood samples from pregnant individuals did not improve risk prediction of hypertensive disorders of pregnancy compared to current methods, underscoring the demand for more accurate prediction tools, according to findings published in JAMA Cardiology.